Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients

NCT02156960 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis

NCT01992159 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)

NCT00620113 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation

NCT00965978 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)

NCT00092027 ·Status: COMPLETED ·Phase: PHASE3

A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)

NCT00092040 ·Status: COMPLETED ·Phase: PHASE3

Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis

NCT00504426 ·Status: COMPLETED ·Phase: PHASE2

Intervention Study of Drugs in Patients Osteopenia and Osteoporosis

NCT04719572 ·Status: UNKNOWN ·Phase: NA

Clinical Study of AK159 in Healthy Postmenopausal Women

NCT01551602 ·Status: COMPLETED ·Phase: PHASE1

Treatment of Osteoporosis - TOP 2-5 Clinical Studies (Pear Control)

NCT05178719 ·Status: COMPLETED ·Phase: NA

Study of Investigational Drug in Osteoporosis (MK-0217-908)

NCT00092053 ·Status: COMPLETED ·Phase: PHASE3

Denosumab China Phase III Study

NCT02014467 ·Status: COMPLETED ·Phase: PHASE3

Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study)

NCT00165607 ·Status: COMPLETED ·Phase: PHASE4

Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients

NCT03755193 ·Status: RECRUITING ·Phase: PHASE2

Anabolic Therapy in Postmenopausal Osteoporosis

NCT05010590 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED)

NCT00480766 ·Status: COMPLETED ·Phase: PHASE3

A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)

NCT00692913 ·Status: COMPLETED ·Phase: PHASE3

Effects of Denosumab Therapy for Japanese

NCT02491515 ·Status: UNKNOWN

Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis

NCT05278338 ·Status: UNKNOWN ·Phase: PHASE2

Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)

NCT00271713 ·Status: COMPLETED ·Phase: PHASE4

Recombinant Human Bone Morphogenetic Protein-2(rhBMP-2) in Patients With Osteoporosis After Lumbar Fusion

NCT05911477 ·Status: UNKNOWN ·Phase: NA

A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis

NCT05067335 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Study of AK159 in Healthy Postmenopausal Women

NCT01935479 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic Subjects

NCT00306189 ·Status: COMPLETED ·Phase: PHASE2

A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis

NCT06804590 ·Status: RECRUITING ·Phase: PHASE3